Extended COVID-19 Care Clinics

These clinics have been launched to help our patients recover safely at home, access outpatient intravenous therapies such as monoclonal antibody treatment when available, and/or receive supportive care in an ambulatory setting as an alternative to an emergency room visit or hospitalization.

The Inova Extended COVID-19 Care Clinics are accepting referrals for patients from all Inova Emergency Rooms, Inova Urgent Care Centers, Inova Primary Care Offices, as well as community practices.

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses. The monoclonal antibody infusions offered specifically target the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells.

Infusion treatment – also known as IV therapy – involves administering medications intravenously. This is done by injecting a needle directly into the patient’s arm. This allows for much more efficient treatment since it delivers medicine directly into the bloodstream.

Patients eligible for monoclonal antibody infusion must:

• Have a positive COVID-19 test (PCR or antigen based) and have experienced symptom onset within the past 10 days
  
  AND
   
• Be at high risk for hospitalization or severe illness
  
  AND
   
• Be referred by a provider to help determine if patient meets the high risk criteria for receiving the infusion treatment.

To be referred, please contact your Inova primary care provider. Your community primary care provider may also refer you using this referral link: inova.org/covidclinic

If you do not have a primary care physician, please call:

• 1-855-IMG-DOCS (464-3627) if you have Medicare or commercial insurance or
• 571-665-6636 if you have Medicaid or are uninsured

• Telemedicine assessments
• Monoclonal antibody infusions or other therapies
• On-site, in-person evaluations and supportive care

The monoclonal antibody infusion treatment is currently available by the FDA through Emergency Use Authorization (EUA).

An Emergency Use Authorization (EUA) is a mechanism to facilitate the availability and use of medical countermeasures, including vaccines, during public health emergencies, such as the current COVID-19 pandemic.

The most common side effect shown in studies has been nausea. This medication has been very well tolerated. Nevertheless, Inova providers will be closely monitoring you for 1 hour after treatment to ensure your safety.

There have not been any studies on pregnant patients. Given the low risk associated with this medication, pregnant patients can receive the treatment if requested.

Inova is not charging for the COVID-19 infusion treatment, but will charge for administering the medication. Charges will vary depending on your coverage.

Uninsured patients can apply for financial assistance. Financial assistance coverage will depend on qualifications.